@article{article, title = {{IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)}}, publisher = {{Elsevier BV}}, url = {{}}, year = {{2016}}, month = {{10}}, author = {{Bellmunt J and Balar A and Galsky MD and Loriot Y and Theodore C and Grande Pulido E and Castellano D and Retz M and Niegisch G and Bracarda S and Necchi A et al}}, doi = {{10.1093/annonc/mdw373.10}}, volume = {{27}}, journal = {{Annals of Oncology}}, pages = {{vi270-vi270}}, note = {{Accessed on 2024/12/21}}}